Fatigue and health-related quality of life in relapsing-remitting multiple sclerosis after 2 years glatiramer acetate treatment are predicted by changes at 6 months: An observational multi-center study
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.